Cancer Research Journal

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Research Article |

GATA3 rs3824662, IKZF1 (rs4132601& rs11978267), and ARID5B (rs10821936 & rs10994982) Gene Polymorphisms in Egyptian Adult Patients with Acute Leukemia

GATA3, IKZF1, and ARID5B polymorphisms are validated risks of pediatric acute lymphoblastic leukemia (ALL) in numerous ethnicities, whilst, their role in adult patients with acute leukemia is less well defined. Objective: The study aims to investigate the association between the GATA3 rs3824662, IKZF1 (rs4132601& rs11978267), and ARID5B (rs10821936 & rs10994982) and the susceptibility to adult acute leukemia, as well as their impact on the treatment outcome. Methods: Real-time PCR was performed for the 5 SNPs in 91 patients (53 ALL and 38 AML) and 194 healthy controls. Results: IKZF1 rs4132601 G allele, G/G and G/T genotypes, as well as G/A haplotype of IKZF1 rs4132601/rs11978267 were significantly higher in ALL vs. healthy controls (p-values were <0.001, 0.001, 0.012, and 0.036, respectively) and in AML vs. healthy controls (p-values were <0.001, 0.001, 0.001, and 0.005, respectively). ARID5B rs10821936 C allele, C/C and C/T genotypes, as well as C/A haplotype of rs10821936/rs10994982 were significantly higher in ALL vs. healthy controls (p-values were <0.001, <0.001, 0.005, and 0.036, respectively), and only C allele and C/C genotype in AML vs. healthy controls (p-values were 0.002 and 0.017, respectively). Shorter Overall Survival (p = 0.003) and lack of remission (p=0.041) were significantly higher in ALL patients harboring IKZF1 rs4132601 G/G genotype. Conclusion: IKZF1 rs4132601 and ARID5B rs10821936 are potential risky SNPs for the development of acute leukemia in Egyptian adults. Furthermore, ALL patients with the IKZF1 rs4132601 GG genotype are probably more prone to poor outcome.

GATA3 rs3824662, IKZF1 rs4132601, IKZF1rs11978267, ARID5B rs10821936, ARID5B rs10994982, ALL, AML

APA Style

Attallah, S. M., Mosaad, Y. M., Taalab, M. M., Eisa, N. N., Hammad, A. M., et al. (2023). GATA3 rs3824662, IKZF1 (rs4132601& rs11978267), and ARID5B (rs10821936 & rs10994982) Gene Polymorphisms in Egyptian Adult Patients with Acute Leukemia. Cancer Research Journal, 11(4), 142-155.

ACS Style

Attallah, S. M.; Mosaad, Y. M.; Taalab, M. M.; Eisa, N. N.; Hammad, A. M., et al. GATA3 rs3824662, IKZF1 (rs4132601& rs11978267), and ARID5B (rs10821936 & rs10994982) Gene Polymorphisms in Egyptian Adult Patients with Acute Leukemia. Cancer Res. J. 2023, 11(4), 142-155. doi: 10.11648/j.crj.20231104.14

AMA Style

Attallah SM, Mosaad YM, Taalab MM, Eisa NN, Hammad AM, et al. GATA3 rs3824662, IKZF1 (rs4132601& rs11978267), and ARID5B (rs10821936 & rs10994982) Gene Polymorphisms in Egyptian Adult Patients with Acute Leukemia. Cancer Res J. 2023;11(4):142-155. doi: 10.11648/j.crj.20231104.14

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License ( which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, Chen W, Chen X, Chng WJ, Choi JK, Colmenero I, Coupland SE, Cross NCP, De Jong D, Elghetany MT, Takahashi E, Emile JF, Ferry J, Fogelstrand L, Fontenay M, Germing U, Gujral S, Haferlach T, Harrison C, Hodge JC, Hu S, Jansen JH, Kanagal-Shamanna R, Kantarjian HM, Kratz CP, Li XQ, Lim MS, Loeb K, Loghavi S, Marcogliese A, Meshinchi S, Michaels P, Naresh KN, Natkunam Y, Nejati R, Ott G, Padron E, Patel KP, Patkar N, Picarsic J, Platzbecker U, Roberts I, Schuh A, Sewell W, Siebert R, Tembhare P, Tyner J, Verstovsek S, Wang W, Wood B, Xiao W, Yeung C, Hochhaus A. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022 Jul; 36(7): 1703-1719.
2. Harris MH, Czuchlewski DR, Arber DA, Czader M. Genetic Testing in the Diagnosis and Biology of Acute Leukemia: 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report, American Journal of Clinical Pathology. 2019 Sep; 152, (3): 322–346.
3. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW. Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of hematology. Arch Pathol Lab Med. 2017; 141(10): 1342-1393.
4. Plasschaert SL, Kamps WA, Vellenga E, de Vries EG, de Bont ES. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation? Cancer Treat Rev. 2004, Feb; 30(1): 37-51.
5. Lim JY, Bhatia S, Robison LL, Yang JJ. Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer. 2014; 120(7): 955-962.
6. Narayanan D, & Weinberg OK. How I investigate acute myeloid leukemia. Int J Lab Hematol. 2020 Feb; 42(1): 3-15.
7. Hunger SP, & Mullighan CG: Acute lymphoblastic leukemia in children. N Engl J Med 2015; 373: 1541–1552.
8. Juliusson, G., & Hough, R. Leukemia. Tumors in Adolescents and Young Adults. Stark DP, Vassal G (eds). Prog Tumor Res. Basel, Karger, 2016; 43: 87-100.
9. Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y, Pounds SB, Neale G, Treviño LR, French D, Campana D, Downing JR, Evans WE, Pui CH, Devidas M, Bowman WP, Camitta BM, Willman CL, Davies SM, Borowitz MJ, Carroll WL, Hunger SP, Relling MV. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA. 2009; 301(4): 393–403.
10. Migliorini G, Fiege B, Hosking FJ, Ma Y, Kumar R, Sherborne AL, da Silva Filho MI, Vijayakrishnan J, Koehler R, Thomsen H, Irving JA, Allan JM, Lightfoot T, Roman E, Kinsey SE, Sheridan E, Thompson P, Hoffmann P, Nöthen MM, Mühleisen TW, Eisele L, Zimmermann M, Bartram CR, Schrappe M, Greaves M, Stanulla M, Hemminki K, Houlston RS. Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Blood. 2013 Nov 7; 122(19): 3298-307.
11. Walsh KM, de Smith AJ, Chokkalingam AP, Metayer C, Roberts W, Barcellos LF, Wiemels JL, Buffler PA. GATA3 risk alleles are associated with ancestral components in Hispanic children with ALL. Blood. 2013 Nov 7; 122(19): 3385-7.
12. Mosaad YM, Elashery R, Darwish A, Sharaf Eldein OA, Barakat T, Marouf S, Abou El-Khier NT, Youssef LF, Fawzy IM. GATA3 rs3824662 gene polymorphism as possible risk factor in a cohort of Egyptian patients with pediatric acute lymphoblastic leukemia and its prognostic impact. Leuk Lymphoma. 2017 Mar; 58(3): 689-698.
13. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, Houlston RS. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009 Sep; 41(9): 1006-10.
14. Treviño LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, Willman C, Neale G, Downing J, Raimondi SC, Pui CH, Evans WE, Relling MV. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009 Sep; 41(9): 1001-5.
15. Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia. J Clin Oncol. 2012 Mar 1; 30(7): 751-7.
16. Evans TJ, Milne E, Anderson D, de Klerk NH, Jamieson SE, Talseth-Palmer BA, Bowden NA, Holliday EG, Rudant J, Orsi L, Richardson E, Lavis L, Catchpoole D, Attia JR, Armstrong BK, Clavel J, Scott RJ. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures. PLoS One. 2014 Oct 13; 9(10): e110255.
17. Rudant J, Orsi L, Bonaventure A, Goujon-Bellec S, Baruchel A, Petit A, Bertrand Y, Nelken B, Pasquet M, Michel G, Saumet L, Chastagner P, Ducassou S, Réguerre Y, Hémon D, Clavel J. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study. PLoS One. 2015 Mar 25; 10(3): e0121348.
18. Mosaad YM, Khashaba M, Darwish A, Darwish M, Elwassefy M, Abdelmabood S, Fawzy IM, Youssef LF, Elbasiouny RA. ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome. Pediatr Hematol Oncol. 2019 Sep; 36(6): 365-375.
19. Olsson L, Johansson B. Ikaros and leukaemia. Br J Haematol. 2015 May; 169(4): 479-91.
20. Cao S, Yang J, Qian X, Jin G, Ma H. The functional polymorphisms of ARID5B and IKZF1 are associated with acute myeloid leukemia risk in a Han Chinese population. Gene. 2018 Mar 20; 647: 115-120.
21. Mosaad YM, El-Ziny MA, Darwish A, Al-Harrass M, Abdmabood S, Fawzy IM, Sherif DM, Yakoub MG, Abdeltawab H. IKZF1 rs4132601 and rs11978267 Gene Polymorphisms and Acute Lymphoblastic Leukemia: Relation to Disease Susceptibility and Outcome. J Pediatr Hematol Oncol. 2020 Oct; 42(7): 420-428.
22. Li JZ, Absher DM, Tang H, worldwide human relationships inferred from genome-wide patterns of variation. Science 2008; 319: 1100–1104.
23. Bolufer P, Barragan E, Collado M, Cervera J, López JA, Sanz MA. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res. 2006 Dec; 30(12): 1471-91.
24. Linet MS, Brown LM, Mbulaiteye SM, Check D, Ostroumova E, Landgren A, Devesa SS. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0-19 years. Int J Cancer. 2016 Apr 15; 138(8): 1862-74.
25. Zhang W, Kuang P, Li H, Wang F, Wang Y. Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis. Ann Hematol. 2017 Feb; 96(2): 215-225.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005 Jan 15; 21(2): 263-5.
27. Xu H, Yang W, Perez-Andreu V, Devidas M, Fan Y, Cheng C, Pei D, Scheet P, Burchard EG, Eng C, Huntsman S, Torgerson DG, Dean M, Winick NJ, Martin PL, Camitta BM, Bowman WP, Willman CL, Carroll WL, Mullighan CG, Bhojwani D, Hunger SP, Pui CH, Evans WE, Relling MV, Loh ML, Yang JJ. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013 May 15; 105(10): 733-42.
28. Burmeister T, Bartels G, Gröger D, Trautmann H, Schwartz S, Lenz K, Tietze-Bürger C, Viardot A, Wäsch R, Horst HA, Reinhardt R, Gökbuget N, Hoelzer D, Kneba M, Brüggemann M. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group. Haematologica. 2014 Feb; 99(2): e23-5.
29. Li S, Ren L, Fan L, Wang G. IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis. Leuk Lymphoma. 2015 Apr; 56(4): 978-82.
30. Horibata S, Gui G, Lack J, DeStefano CB, Gottesman MM, Hourigan CS. Heterogeneity in refractory acute myeloid leukemia. Proc Natl Acad Sci U S A. 2019 May 21; 116(21): 10494-10503.
31. Park SS, & Baek KH. Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins. Int J Mol Sci. 2022 Jan 3; 23(1): 514.
32. Jain N, Zhang H, Roberts KG, Qian M, Yang W, Jabbour EJ, Kantarjian HM, Mullighan CG, YangJJ, Konopleva M. GATA3 rs3824662A Allele Is Overrepresented in Adult Patients with Ph-like ALL, Especially in Patients with CRLF2 Abnormalities. Blood, 2017; 130 (1): 1430.
33. Koller PB, Zhang H, Kantarjian H, Jabbour E, Pierce S, Gocho Y, Roberts KG, Yang W, Mullighan CG, Yang J, Konopleva M, Jain N. GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis. Am J Hematol. 2021 Mar 1; 96(3): E71-E74.
34. Iacobucci I, Storlazzi CT, Cilloni D, Lonetti A, Ottaviani E, Soverini S, Astolfi A, Chiaretti S, Vitale A, Messa F, Impera L, Baldazzi C, D'Addabbo P, Papayannidis C, Lonoce A, Colarossi S, Vignetti M, Piccaluga PP, Paolini S, Russo D, Pane F, Saglio G, Baccarani M, Foà R, Martinelli G. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). Blood. 2009 Sep 3; 114(10): 2159-67.
35. Fang Q, Zhao X, Li Q, Li Y, Liu K, Tang K, Wang Y, Liu B, Wang M, Xing H, Rao Q, Tian Z, Wang J, Mi Y. IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia. Leuk Lymphoma. 2017 Jan; 58(1): 127-137.
36. Lopes BA, Barbosa TC, Souza BKS, Poubel CP, Pombo-de-Oliveira MS, Emerenciano M; Brazilian Study Group for Childhood Leukemia. IKZF1 Gene in Childhood B-cell Precursor Acute Lymphoblastic Leukemia: Interplay between Genetic Susceptibility and Somatic Abnormalities. Cancer Prev Res (Phila). 2017 Dec; 10(12): 738-744.
37. Giebel S, Labopin M, Socié G, Beauvais D, Klein S, Wagner-Drouet EM, Blaise D, Nguyen-Quoc S, Bourhis JH, Thiebaut A, Labussière-Wallet H, Charbonnier A, Berceanu A, Diez-Martin JL, Fegueux N, Esteve J, Nagler A, Mohty M. Allogeneic HCT for adults with B-cell precursor acute lymphoblastic leukemia harboring IKZF1 gene mutations. A study by the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant. 2021 May; 56(5): 1047-1055.
38. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 1994 Oct 7; 79(1): 143-56.
39. Zhou J, Gou H, Zhang L, Wang X, Ye Y, Lu X, Ying B. ARID5B Genetic Polymorphisms Contribute to the Susceptibility and Prognosis of Male Acute Promyelocytic Leukemia. DNA Cell Biol. 2019 Nov; 38(11): 1374-1386.